HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,763 | +10.2% | 46,148 | +4.0% | 0.27% | +13.0% |
Q2 2023 | $1,600 | -13.1% | 44,355 | -8.0% | 0.24% | -17.9% |
Q1 2023 | $1,841 | -34.3% | 48,201 | -2.1% | 0.29% | -38.5% |
Q4 2022 | $2,801 | -99.8% | 49,226 | +50.8% | 0.47% | +117.0% |
Q3 2022 | $1,291,000 | – | 32,649 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,816,162 | $191,226,000 | 8.73% |
BB BIOTECH AG | 6,825,532 | $65,866,000 | 2.13% |
Lombard Odier Asset Management (USA) Corp | 2,700,000 | $26,055,000 | 1.79% |
SECTORAL ASSET MANAGEMENT INC | 3,724,351 | $35,940,000 | 1.61% |
QVT Financial LP | 2,010,186 | $19,398,000 | 0.97% |
JHL Capital Group LLC | 1,475,000 | $14,234,000 | 0.94% |
MAZAMA CAPITAL MANAGEMENT INC | 358,087 | $3,456,000 | 0.79% |
EcoR1 Capital, LLC | 160,700 | $1,551,000 | 0.78% |
Alden Global Capital Ltd | 332,500 | $3,209,000 | 0.77% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 7,274,065 | $70,195,000 | 0.65% |